Back to top
Raised to Date: 
Current Interests: 
$1,000 - $2,500

Invest Now
 Coming Soon
Test the Waters
Accredited Only: 
Reviewed Financials: 
Issue Type: 
Test the Waters
Minimum Investment: 
Target Goal: 
Minimum Goal: 
Suggested Investment: 
Additional Investments: 
Maximum Goal: 
Raise Start Date: 
Sunday, May 15, 2022
Raise End Date: 
Saturday, December 31, 2022
Raise Target Date: 
Sunday, May 15, 2022

Welcome Testing The Waters visitors.

Click "I am Interested" to share investment expectations with this business.


Offering Overview

As an investor, we know you have many options to invest. The digital logistics sector has been one of the most sought after investment markets due to exponential growth in technological advancements. Balto Rx is capitalizing on this trend by revolutionizing medication delivery services through the use of our digital platform, called Balto Intelligent Platform (BIP). The BIP provides user-friendly tools to help all pharmacies, hospitals, clinics, and patients get their prescriptions delivered to their home within hours. Additionally, Balto Rx is the only home delivery company that provides pharmacist-patient video consultation in real-time. We strive to be patient-centric and break barriers to medication access so millions of people nationwide can improve their health and wellbeing. If you believe in medication accessibility and growing your investment portfolio in digital logistics, then choose Balto Rx. Investing in us would help improve the lives of millions of people with limited access to medications–investing in us is an investment for good.


According to CMS (Centers for Medicare and Medicare Services) up to 30% to 50% of patients do not have access to their medications. Due to the increased cost of healthcare over the last decade in the United States, there are decreased rates of medication adherence. Research shows the lack of medication adherence is often a result of patient forgetfulness, high cost, inability to get prescriptions filled, and limited access to pick-up or delivery options.

At its core, BaltoRx is a patient-centric home delivery system for medical prescriptions. But I believe it’s so much more than that. We are providing a critical service to many individuals and families who may not have adequate access to transportation, the ability to leave their homes, or time to run even a quick errand due to demanding life schedules. And, as one of the 130 million adults in America who has been diagnosed with Diabetes, I understand how crucial medications can be in maintaining a healthy lifestyle. We strive to increase access to the millions of people who are impacted by all chronic illness and health challenges.


Hospitals, healthcare workers, insurance companies, and other leaders in the industry have sought to increase accessibility of medications by creating delivery systems. However, the most current delivery programs are not effective and more importantly do not address immediacy; meaning it can take up to 2-5 business days for a medication to be delivered. Other large retailers are also focused on delivering solely to their own clientele, leaving out millions of people who need medications. BaltoRx is the only direct service provider focused on patient-centered care and improving access to prescriptions by delivering medications to the patient within hours of a request.

Statistics show over 5 billion medical prescriptions were dispensed in the United States in 2020, and that number is steadily increasing every year. Less than 1% of those 5 billion prescriptions were delivered, which leaves a 99% open market for prescription delivery. Balto Rx is filling this gap with daily and on-demand services that provide prescription deliveries within hours.

North America Drug Delivery Market – Forecasts from 2021 to 2026 and is projected to grow at a CAGR of 10.04% to reach US$657.83 billion by year 2026 from US$336.76 billion in 2019.

Currently, Balto Rx has delivered 21,000+ prescriptions and counting. Based on the market growth, we are estimating multi-million dollar revenue in the next decade.

There are approximately 67,000 pharmacies in the United States. A majority of pharmacies don’t offer home-delivery services. In the current healthcare landscape, only less than 1% of mass retailers are providing delivery services, which leaves a large percentage of vulnerable populations--such as the elderly, people with disabilities, and people with limited access to transportation--in need of medications delivery services (Source: Wikipedia). Balto Rx is expanding into more than 2,100 zip codes in 14 states, and expanding our pool of drivers by increasing hiring and tapping into our partners’ networks.


Balto Rx is meeting the moment by helping increase access to medications for patients. We are ready to partner with all pharmacies (independent, chain, or specialty), hospitals, insurance companies and others in the healthcare ecosystem. To meet the increased demand, we have introduced “Meds On-demand,” a service where patients and pharmacies can request medications to be delivered from any pharmacy, any day, at any time.

Balto Rx has become a successful platform for delivering prescription medications to a patient’s home from their local pharmacy, within hours of a request. Balto Intelligent Platform (BIP) is the most advanced and comprehensive digital platform that streamlines the prescription delivery process through features including proof of delivery, real-time tracking, prescription transfers, and many more. We have also created associated apps, including “DeliverMyRx” for patients to request their medications; “See-a-pharm” app for video consultation with a pharmacist; and others for healthcare agencies to place orders on behalf of the patient, even while a patient is being discharged from a hospital.

Our innovative, HIPAA-compliant model is revolutionizing the way prescription medications are delivered across the country. With deliveries starting at just $7, Balto Rx is paving the way for new opportunities in healthcare accessibility by creating the most affordable and timely delivery services out there.

Balto Rx generates revenue through our various services, including our daily deliveries, which are contract-based partnerships with pharmacies and hospitals and generate a steady stream of revenue; our “On-demand” services allow for pharmacies and hospitals to request deliveries as needed, at a higher rate per delivery; lastly, the “DeliverMyRx” is an app that allows patients to submit delivery requests, which also generates revenue.


After a successful pilot run in Q4 of 2019, we launched commercial delivery services in January 2020 within the State of California. Since then, BaltoRx has partnered with 50+ hospitals/pharmacies, delivered over 21,000+ medications, completed over 7,000+ deliveries, and has seen a 125% increase in YTY (2020 to 2021) revenue. Our ultimate mission is to expand across the nation to reach millions of people and bring improved access to medications.

Balto Rx is paving the way for new opportunities in healthcare accessibility by creating reliable, accessible, and timely delivery services. In addition, Balto Rx is the only company providing direct patient to pharmacist video consultation services. We are also excited to be expanding our impact and network of drivers through a collaboration with a ride sharing company.

We have been self funded from the beginning and have gone through many phases of research, design, development, testing, pilot then commercial launch. Now we are seeking greater resources from external funders for the expansion phase.


CEO - Hemant Shah is a passionate entrepreneur with over 30 years of experience focused on developing state-of-the-art technologies that aim to expand the digital landscape. He has founded and developed companies that deliver computer hardware, software, and service-related technological solutions and is now embarking on his latest project, Balto Rx.

Directors: 2 healthcare professionals acting as advisory members who provide insight and direction on healthcare related issues and challenges.

Technical Director: oversees the digital platform for general use to pharmacies, hospitals, clinics, and end users (patients).

Communications Director: manages and develops public relations, media, and communications content.

Advisors: 3 pharmaceutical professionals help advance and develop strategy, trends and upcoming pharmacy regulations.


If we’re only able to raise the minimum amount, we would use whatever funds we’ve secured to hire new drivers, which would help us on our mission to increase access to medications for everyone.

To reach our goal, we are hoping to raise $250,000.00 to $500,000.00. To be specific, 50% of this will help us expand our reach by hiring more quality drivers in new cities; 30% will help us increase our staff capacity to ensure operations run smoothly during our expansion by allowing us to hire multiple new positions; and 20% will help us improve our user-friendly technological features and fund new initiatives to reach more underserved communities across the nation.z

Required investment to support the following activities:

  • Marketing & advertisement

  • Recruiting sales personnel

  • Recruiting direct clients, pharmacies and hospitals

  • Recruiting our own drivers throughout service regions.

  • Ongoing engineering fees

  • Operating expenses

  • Returning initial investment

  • Licenses & Legal Framework

o   Licenses requirements from American Pharmacist Association, AMA and any other Healthcare Organization.

o   Legal protection

  • Eco-system Framework

  • Leading pharmacies such as Walgreens, CVS, Rite Aid, Walmart etc.

  • Mid-sized & private pharmacies in individual cities & states

  • Hospitals

  • Insurance companies

  • Medicare & Medicaid

  • Individual physician & Medical Groups

  • 2nd tier healthcare providers such as AARP and similar agencies.

Break Even

We are estimating to break-even within 2 - 3 years after being fully funded.


Upon considerable funding from investor(s), Balto Rx will have multiple options to offer (ROI), including: common stock, preferred stock, interest-bearing loans, revenue-sharing arrangements, convertible debt, and future equity.

Disclosure: this page represents Testing The Waters materials.

  1. No funds or other consideration is being solicited, and if money is sent, it will not be accepted by the company; 
  2. No sales will be performed or commitments to purchase accepted until the offering statement is qualified; and
  3. A proposed purchaser’s indication of interest is non-binding.